Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model

Background/Aim. The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic factors. The estimated 5-year survival in patients with a high FLIPI score is around 50%. The aim of this study was...

Full description

Bibliographic Details
Main Authors: Anđelić Boško, Todorović-Balint Milena, Antić Darko, Bila Jelena, Đurašinović Vladislava, Mihaljević Biljana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2015-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501501026A.pdf
_version_ 1818930872383963136
author Anđelić Boško
Todorović-Balint Milena
Antić Darko
Bila Jelena
Đurašinović Vladislava
Mihaljević Biljana
author_facet Anđelić Boško
Todorović-Balint Milena
Antić Darko
Bila Jelena
Đurašinović Vladislava
Mihaljević Biljana
author_sort Anđelić Boško
collection DOAJ
description Background/Aim. The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic factors. The estimated 5-year survival in patients with a high FLIPI score is around 50%. The aim of this study was to analyse the prognostic value of clinical and laboratory parameters that are not included in the FLIPI and the New Prognostic Index for Follicular Lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project (FLIPI2) indices, in follicular lymphoma (FL) patients with a high FLIPI score and high tumor burden. Methods. The retrospective analysis included 57 newly diagnosed patients with FL, a high FLIPI score and a high tumor burden. All the patients were diagnosed and treated between April 2000 and June 2007 at the Clinic for Hematology, Clinical Center of Serbia, Belgrade. Results. The patients with a histological grade > 1, erythrocyte sedimentation rate (ESR) ± 45 mm/h and hypoalbuminemia had a significantly worse overall survival (p = 0.015; p = 0.001; p = 0.008, respectively), while there was a tendency toward worse overall survival in the patients with an Eastern Cooperative Oncology Group (ECOG) > 1 (p = 0.075). Multivariate Cox regression analysis identified a histological grade > 1, ESR ± 45 mm/h and hypoalbuminemia as independent risk factors for a poor outcome. Based on a cumulative score of unfavourable prognostic factors, patients who had 0 or 1 unfavourable factors had a significantly better 5-year overall survival compared to patients with 2 or 3 risk factors (75% vs 24.1%, p = 0.000). Conclusion. The obtained results suggest that from the examined prognostic parameters histological grade > 1, ESR ± 45 mm/h and hypoalbuminemia can contribute in defining patients who need more aggressive initial treatment approach, if two or three of these parameters are present on presentation.
first_indexed 2024-12-20T04:07:36Z
format Article
id doaj.art-06c99383544a464491ddae812df61af4
institution Directory Open Access Journal
issn 0042-8450
language English
last_indexed 2024-12-20T04:07:36Z
publishDate 2015-01-01
publisher Military Health Department, Ministry of Defance, Serbia
record_format Article
series Vojnosanitetski Pregled
spelling doaj.art-06c99383544a464491ddae812df61af42022-12-21T19:53:59ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502015-01-01721263210.2298/VSP1501026A0042-84501501026AFollicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification modelAnđelić Boško0Todorović-Balint Milena1Antić Darko2Bila Jelena3Đurašinović Vladislava4Mihaljević Biljana5Clinical Center of Serbia, Clinic for Hematology, BelgradeClinical Center of Serbia, Clinic for Hematology, Belgrade + Faculty of Medicine, BelgradeClinical Center of Serbia, Clinic for Hematology, Belgrade + Faculty of Medicine, BelgradeClinical Center of Serbia, Clinic for Hematology, Belgrade + Faculty of Medicine, BelgradeClinical Center of Serbia, Clinic for Hematology, BelgradeClinical Center of Serbia, Clinic for Hematology, Belgrade + Faculty of Medicine, BelgradeBackground/Aim. The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic factors. The estimated 5-year survival in patients with a high FLIPI score is around 50%. The aim of this study was to analyse the prognostic value of clinical and laboratory parameters that are not included in the FLIPI and the New Prognostic Index for Follicular Lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project (FLIPI2) indices, in follicular lymphoma (FL) patients with a high FLIPI score and high tumor burden. Methods. The retrospective analysis included 57 newly diagnosed patients with FL, a high FLIPI score and a high tumor burden. All the patients were diagnosed and treated between April 2000 and June 2007 at the Clinic for Hematology, Clinical Center of Serbia, Belgrade. Results. The patients with a histological grade > 1, erythrocyte sedimentation rate (ESR) ± 45 mm/h and hypoalbuminemia had a significantly worse overall survival (p = 0.015; p = 0.001; p = 0.008, respectively), while there was a tendency toward worse overall survival in the patients with an Eastern Cooperative Oncology Group (ECOG) > 1 (p = 0.075). Multivariate Cox regression analysis identified a histological grade > 1, ESR ± 45 mm/h and hypoalbuminemia as independent risk factors for a poor outcome. Based on a cumulative score of unfavourable prognostic factors, patients who had 0 or 1 unfavourable factors had a significantly better 5-year overall survival compared to patients with 2 or 3 risk factors (75% vs 24.1%, p = 0.000). Conclusion. The obtained results suggest that from the examined prognostic parameters histological grade > 1, ESR ± 45 mm/h and hypoalbuminemia can contribute in defining patients who need more aggressive initial treatment approach, if two or three of these parameters are present on presentation.http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501501026A.pdflymphomafollicularantineoplastic combined chemotherapy protocolsprognosis
spellingShingle Anđelić Boško
Todorović-Balint Milena
Antić Darko
Bila Jelena
Đurašinović Vladislava
Mihaljević Biljana
Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
Vojnosanitetski Pregled
lymphoma
follicular
antineoplastic combined chemotherapy protocols
prognosis
title Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
title_full Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
title_fullStr Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
title_full_unstemmed Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
title_short Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model
title_sort follicular lymphoma patients with a high flipi score and a high tumor burden a risk stratification model
topic lymphoma
follicular
antineoplastic combined chemotherapy protocols
prognosis
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501501026A.pdf
work_keys_str_mv AT anđelicbosko follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel
AT todorovicbalintmilena follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel
AT anticdarko follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel
AT bilajelena follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel
AT đurasinovicvladislava follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel
AT mihaljevicbiljana follicularlymphomapatientswithahighflipiscoreandahightumorburdenariskstratificationmodel